Convalescent Plasma as Treatment for Acute Coronavirus Disease (COVID-19)
Clinical trial NCT04390178 · COMPLETED
Trial details
- NCT number
- NCT04390178
- Sponsor
- Joakim Dillner
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-04-10
- Primary completion
- 2020-06-30
- Enrollment
- 10
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.